These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 33127185

  • 1. Drug checking identifies counterfeit alprazolam tablets.
    Tobias S, Shapiro AM, Grant CJ, Patel P, Lysyshyn M, Ti L.
    Drug Alcohol Depend; 2021 Jan 01; 218():108300. PubMed ID: 33127185
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.
    Crepeault H, Socias ME, Tobias S, Lysyshyn M, Custance A, Shapiro A, Ti L.
    Drug Alcohol Rev; 2023 Mar 01; 42(3):538-543. PubMed ID: 36423900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
    Ti L, Tobias S, Maghsoudi N, Milloy MJ, McDonald K, Shapiro A, Beriault D, Stefan C, Lysyshyn M, Werb D.
    Drug Alcohol Rev; 2021 May 01; 40(4):580-585. PubMed ID: 33354869
    [Abstract] [Full Text] [Related]

  • 13. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S, Janssen RM, Olson K, Bridgeman J, Korol EE, Chu T, Ghafari C, Sabeti S, Buxton JA, Lysyshyn M.
    Int J Drug Policy; 2022 Aug 01; 106():103741. PubMed ID: 35671687
    [Abstract] [Full Text] [Related]

  • 14. Motivators of and barriers to drug checking engagement in British Columbia, Canada: Findings from a cross-sectional study.
    Tobias S, Ferguson M, Palis H, Burmeister C, McDougall J, Liu L, Graham B, Ti L, Buxton JA.
    Int J Drug Policy; 2024 Jan 01; 123():104290. PubMed ID: 38101275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
    Ti L, Tobias S, Lysyshyn M, Laing R, Nosova E, Choi J, Arredondo J, McCrae K, Tupper K, Wood E.
    Drug Alcohol Depend; 2020 Jul 01; 212():108006. PubMed ID: 32438280
    [Abstract] [Full Text] [Related]

  • 18. Genuine and counterfeit prescription pill surveillance in Washington, D.C.
    Nguyen L, Evans A, Frank G, Levitas M, Mennella A, Short LC.
    Forensic Sci Int; 2022 Oct 01; 339():111414. PubMed ID: 35973357
    [Abstract] [Full Text] [Related]

  • 19. Costing analysis of a point-of-care drug checking program in Rhode Island.
    Cepeda JA, Thompson E, Ujeneza M, Tardif J, Walsh T, Morales A, Rosen JG, Green TC, Park JN.
    Drug Alcohol Depend; 2023 Dec 01; 253():111028. PubMed ID: 38000322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.